Therefore, for cancers loss of cGAS-STING function, oncolytic virus is prospective in combating this immune evasion, and the therapeutic effects can be predicted by measuring expressional levels of cGAS or STING in biopsy specimens. The gene discussed is STING1; the disease is cancer.